ロード中...

NOVEL PROTEIN THERAPEUTICS FOR SYSTOLIC HEART FAILURE: CHRONIC SUBCUTANEOUS BNP

OBJECTIVES: The objective of the present study was to translate our laboratory investigations to establish safety and efficacy of 8 weeks of chronic SQ BNP administration in human Stage C HF. BACKGROUND: B-Type natriuretic peptide (BNP) is a cardiac hormone with vasodilating, natriuretic, renin-angi...

詳細記述

保存先:
書誌詳細
主要な著者: Chen, Horng H., Glockner, James F, Schirger, John A., Cataliotti, Alessandro, Redfield, Margaret M., Burnett, John C.
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555560/
https://ncbi.nlm.nih.gov/pubmed/23122795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.07.056
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!